The global mycotoxin testing market is poised for substantial growth, with its valuation expected to rise from 𝐔𝐒𝐃 ...

Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications (NDAs) for lenacapavir ...

Your IP is registered with the company mentioned above and provides access to Life Science Sweden.

In a study of 14,384 patients with hypertension presenting to primary care centers, women and men received similar numbers of antihypertensive medications but different dosages and types, with ...